Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Vion (formerly Oncorx) interesting play on Gene Therapy -- Ignore unavailable to you. Want to Upgrade?

To: gonnahappensoon who wrote (367)	1/24/2008 7:27:30 PM
From: buffalodon2003	Respond to of 370

I concur. The announcement of a reverse split provicized the non-buying fate. Basically, it has been a slow drop (longs selling). I fear the worst tomorrow. I will probably sell at any sign of a small movement tomorrow (up .01). I was hoping to hang in there until 2/13 as long as price stayed at or above .50 pps. I am very disappointed. If I re-enter, it would be post 2/13 and only if stock drops back down. I believe that less than one year would exist before another delisting deadline/reverse split again because I believe the FDA would make their decision regarding approval. I hope this thing drops to below 1.00 around January next year this time. IMHO, somewhere after this date, the FDA will make their decision. I feel very bad for anyone staying in. The only risk would be an "out of nowhere partner/buyout", but the stock is way too low to pull it up to that $7 -10 range where IMHO this needs to be for those two events to occur. The other risk is a cancellation of 2/13 meeting and stock I believe will rise back up to .65+ range. Of course, they could do a 180 and go for the treasury stock route and push up pps. Good luck